Skip to main content

Rates of Dissatisfaction High for Hidradenitis Suppurativa Care

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 7, 2025.

via HealthDay

MONDAY, April 7, 2025 -- The rates of respondent dissatisfaction with current hidradenitis suppurativa (HS) treatment options are high, likely due to undertreatment with available therapies, according to study published in the April issue of the Journal of Drugs in Dermatology.

Andeulazia Murdock, from the George Washington School of Medicine and Health Sciences in Washington, D.C., and colleagues distributed a survey to examine perceptions of current and emerging HS treatments and their impact on quality of life among respondents aged 18 years and older. Overall, 423 participants completed the entire survey.

The researchers found that <20 percent of respondents (76/423) were satisfied or very satisfied with current treatment options. Only 39 and/or 26 percent of the 244 patients with self-reported disease severity of Hurley stage II or III were being treated with biologics and/or hormone therapy, respectively, indicating undertreatment per current guidelines. Seventy-four percent of the respondents were unaware of U.S. Food and Drug Administration-approved treatments; more than half (56 percent) reported that these options had not been discussed by their dermatologist or health care provider. Sixty percent of respondents felt it was important to have FDA-approved therapies, believing it would result in improved physical health, mental health, and/or personal relationships (86, 78, and 60 percent, respectively).

"Our goal with this study was to highlight the multifaceted positive impact of new FDA treatments on those living with hidradenitis and the importance of pharma investment in this space," coauthor Adam Friedman, M.D., also from the George Washington School of Medicine and Health Sciences, said in a statement. "We also found that there are still significant gaps in care and dissatisfaction with current treatment approaches."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

32 Percent of U.S. Adults Consumed Fast Food on a Given Day in 2021 to 2023

FRIDAY, June 27, 2025 -- Over 30 percent of adults and children consumed fast food on a given day during August 2021 to August 2023, according to two reports from the National...

Disparities Seen in Continuous Glucose Monitor Rx by Language Preference

FRIDAY, June 27, 2025 -- For patients with type 2 diabetes (T2D), disparities in continuous glucose monitor (CGM) prescriptions are seen by language preference, with less access...

Survey Shows Few Adults Recognize Testicular Cancer as Affecting Young Men

FRIDAY, June 27, 2025 -- Only one in 10 U.S. adults correctly identified testicular cancer as most commonly affecting men under age 40, according to a survey released June16 by...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.